[[Image:PhRMA Logo.jpg|thumb|right|200px|Logo of the Pharmaceutical Research and Manufacturers of America.]]
'''Pharmaceutical Research and Manufacturers of America''' ('''PhRMA''', pronounced {{IPA|/ˈfɑrmə/}}), founded in 1958, is a trade group representing the [[pharmaceutical]] research and biopharmaceutical companies in the [[United States]].  PhRMA's stated mission is advocacy for public policies that encourage the discovery of new medicines for patients by pharmaceutical and biopharmaceutical research companies.  PhRMA's current CEO is [[John J. Castellani]].

==Mission==

On its website, PhRMA states its "mission is winning advocacy for public policies that encourage the discovery of life-saving and life-enhancing new medicines for patients by pharmaceutical / biotechnology research companies.  To accomplish this mission, PhRMA is dedicated to achieving in Washington, D.C., the states and the world:<ref>{{cite web|url=http://www.phrma.org/about/about-phrma-main|title=Mission Statement|publisher=PhRMA|accessdate=2011-02-06}}</ref>
* "Broad patient access to safe and effective medicines through a free market, without price controls,
* "Strong intellectual property incentives, and
* "Transparent, efficient, regulation and a free flow of information to patients."

==Leadership==

===Billy Tauzin===
{{Main article|Billy Tauzin}}
Tauzin started as CEO in 2005<ref name=sarasohn2004>Judy Sarasohn [http://www.washingtonpost.com/wp-dyn/articles/A3504-2004Dec15.html Special Interests: Tauzin to Head Drug Trade Group] ''The Washington Post'' December 16, 2004; Page A35.</ref> and continued until he stepped down in 2010.<ref name=pecquet2010>Julian Pecquet. "PhRMA picks new president" ''The Hill'' July 14, 2010. Vol. 17 Issue 81 page 22.</ref>

===Chris Viehbacher===

Chris Viehbacher is the Chairman of PhRMA's board of directors. Since 2008 Viehbacher has also served as CEO of [[Sanofi-Aventis]].  He was born on 26 March 1960. He holds both German and Canadian nationalities. Viebacher is a certified public accountant. He graduated from [[Queens University]] in Canada.<ref name=Viehbacher>{{cite web
 |url=http://www.phrma.org/chris-viehbacher-biography |title=Chris Viehbacher Biography |publisher=Pharmaceutical Research and Manufacturers of America |accessdate=6 April 2011 }}</ref>

===John J. Castellani===
{{main | John J. Castellani}}

[[John J. Castellani]] is President and CEO of PhRMA. Castellani has promised that PhRMA will continue to support healthcare reform efforts in the United States and abroad. Specifically, PhRMA will focus on helping to successfully implement and improve the health reform legislation passed in 2010 under President Obama with a particular emphasis on rewarding innovation.<ref name=Whorunsgov>[http://www.whorunsgov.com/Profiles/John_Castellani whorunsgov.com]</ref>[[Jeffrey Kindler]], the chairman of Pfizer and former chairman of PhRMA, when commenting on Castellani's move from the [[Business Roundtable]] to PhRMA, said, “John is the gold standard, and I’m extremely pleased that he will lead our team."<ref name=Post/> Mr. Castellani succeeds [[Billy Tauzin]], a former Republican congressman from Louisiana.<ref name=Post>[http://www.washingtonpost.com/wp-dyn/content/article/2010/07/13/AR2010071302891.html Pharmaceutical group shifts tone with new pick for president], by N.C. Alzenman and Dan Eggen, The Washington Post, 14 July 2010</ref>

===tabular listing===
{| class="wikitable sortable"
|-
! Title !! Name !! Start year || End year
|-
| President & CEO || Billy Tauzin<ref name=sarasohn2004/><ref name=pecquet2010/> || 2005 || 2010
|-
| CEO || Alan Holmer<ref name=sarasohn2004/> ||  || 2005
|-
| President & CEO || John J. Castellani<ref name=Post/> || 2010 ||
|-
| Chairman || Chris Viehbacher ||  ||
|}

==American Legislative Exchange Council==
Jeffery Bond, representing PhRMA, sits on the Private Enterprise Board of the [[American Legislative Exchange Council]] (ALEC).<ref>http://www.alec.org/about-alec/private-enterprise-board/</ref>

==Issues==

===Medicare part D===
{{Main|Medicare Part D}}
{{Expand section|date=April 2011}}

===Patient Protection and Affordable Care Act===
{{Main|Patient Protection and Affordable Care Act}}
{{Expand section|date=April 2011}}

===Intellectual property===

Every year, PhRMA makes substantial efforts with regard to [[Special 301 Report]] issued by the [[Office of the United States Trade Representative]] on the enforcement of intellectual property laws abroad.{{Citation needed|date=April 2011}} PhRMA's recommendations for the Special 301 Report in 2009 were especially critical of the Philippines for "breaking patents" and failing to abide by the [[Agreement on Trade-Related Aspects of Intellectual Property Rights]], commonly known as TRIPS.<ref name="RP">{{cite news |title= US lobby wants RP penalized for cheaper drugs law |author= Jessica Anne D. Hermosa |newspaper=BusinessWorld |date=4 March 2009 |accessdate=29 April 2011}}</ref>

==Programs for patients==
===SMARxT Disposal===

SMARxT Disposal is a joint program run by the [[U.S. Fish and Wildlife Service]], the [[American Pharmacists Association]], and PhRMA to encourage consumers to properly dispose of unused medicines in order to avoid harm to the environment.<ref name="Patient">{{cite web |url=http://www.phrma.org/research/patient-resources |title=Patient Resrouces |publisher=Pharmaceutical Research and Manufacturers of America |accessdate=6 April 2011}}</ref>

===Partnership for Prescription Assistance===

The Partnership for Prescription Assistance is a program by PhRMA and its member companies that connects patients in-need with information on low-cost and free prescription medication.<ref name="Patient"/>

==Members==

Some prominent members of PhRMA include the following.  A full list of members is available at the PhRMA website.<ref>[http://www.phrma.org/about/member-companies]</ref>

* [[AstraZeneca]]
* [[Bayer]]
* [[Boehringer Ingelheim]]
* [[Bristol-Myers Squibb]]
* [[Eli Lilly and Company]]
* [[Genzyme Corporation]]
* [[GlaxoSmithKline]]
* [[Merck & Co.|Merck]]
* [[Novartis]]
* [[Pfizer]]
* [[Sanofi-Aventis]]

==See also==
* ''[[Big Pharma|Big Pharma: How the World's Biggest Drug Companies Control Illness]]'' 
* [[European Federation of Pharmaceutical Industries and Associations]] (EFPIA)
* [[Food and Drug Administration]] (FDA, USA)
* [[International Federation of Pharmaceutical Manufacturers Associations]] (IFPMA)
* [[International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use]] (ICH)
* [[Japan Pharmaceutical Manufacturers Association]] (JPMA)
* [[Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme]]
* [[SAFE-BioPharma Association]] (SAFE)
*[[International Intellectual Property Alliance]] (IIPA)

==References==
<references/>

==External links==
* [http://www.phrma.org/ Official website]
{{Use dmy dates|date=April 2011}}

{{DEFAULTSORT:Pharmaceutical Research And Manufacturers Of America}}
[[Category:Lobbying organizations in the United States]]
[[Category:Pharmaceutical industry trade groups]]
[[Category:Political advocacy groups in the United States]]
[[Category:1958 establishments in the United States]]
[[Category:Organizations established in 1958]]